Therapeutic Properties of Mushrooms in Managing Adverse Effects in the Metabolic Syndrome
Abstract
Metabolic syndrome (MS) is a modern medical condition characterized by central obesity, hyperglycaemia, hypercholesterolemia and hypertension. The beneficial effects of mushrooms in lowering the symptoms of MS were known from both traditional and conventional medicine. Edible mushrooms, their extracts, polysaccharide fractions and isolated compounds possessed hypoglycaemic, cholesterol and triglyceride lowering ability, hypotensive effects, as well as weight managing activity by influencing satiety. The most active compounds are polysaccharides, called - glucans, as well as lectines and small compounds such as eritadenin, triterpenes, sterols and phenolic compounds.
Keywords:
Antihypertensive / hypoglycaemic / hypolipidemic / mushrooms / metabolic syndrome / weight lossSource:
Current topics in medicinal chemistry, 2013, 13, 21, 2734-2744Publisher:
- Bentham Science Publ Ltd, Sharjah
Funding / projects:
- Investigation on the medicinal plants: morphological, chemical and pharmacological characterisation (RS-173021)
DOI: 10.2174/15680266113136660196
ISSN: 1568-0266
PubMed: 24083790
WoS: 000326986900006
Scopus: 2-s2.0-84903666946
Collections
Institution/Community
PharmacyTY - JOUR AU - Kundaković, Tatjana AU - Kolundžić, Marina PY - 2013 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1898 AB - Metabolic syndrome (MS) is a modern medical condition characterized by central obesity, hyperglycaemia, hypercholesterolemia and hypertension. The beneficial effects of mushrooms in lowering the symptoms of MS were known from both traditional and conventional medicine. Edible mushrooms, their extracts, polysaccharide fractions and isolated compounds possessed hypoglycaemic, cholesterol and triglyceride lowering ability, hypotensive effects, as well as weight managing activity by influencing satiety. The most active compounds are polysaccharides, called - glucans, as well as lectines and small compounds such as eritadenin, triterpenes, sterols and phenolic compounds. PB - Bentham Science Publ Ltd, Sharjah T2 - Current topics in medicinal chemistry T1 - Therapeutic Properties of Mushrooms in Managing Adverse Effects in the Metabolic Syndrome VL - 13 IS - 21 SP - 2734 EP - 2744 DO - 10.2174/15680266113136660196 ER -
@article{ author = "Kundaković, Tatjana and Kolundžić, Marina", year = "2013", abstract = "Metabolic syndrome (MS) is a modern medical condition characterized by central obesity, hyperglycaemia, hypercholesterolemia and hypertension. The beneficial effects of mushrooms in lowering the symptoms of MS were known from both traditional and conventional medicine. Edible mushrooms, their extracts, polysaccharide fractions and isolated compounds possessed hypoglycaemic, cholesterol and triglyceride lowering ability, hypotensive effects, as well as weight managing activity by influencing satiety. The most active compounds are polysaccharides, called - glucans, as well as lectines and small compounds such as eritadenin, triterpenes, sterols and phenolic compounds.", publisher = "Bentham Science Publ Ltd, Sharjah", journal = "Current topics in medicinal chemistry", title = "Therapeutic Properties of Mushrooms in Managing Adverse Effects in the Metabolic Syndrome", volume = "13", number = "21", pages = "2734-2744", doi = "10.2174/15680266113136660196" }
Kundaković, T.,& Kolundžić, M.. (2013). Therapeutic Properties of Mushrooms in Managing Adverse Effects in the Metabolic Syndrome. in Current topics in medicinal chemistry Bentham Science Publ Ltd, Sharjah., 13(21), 2734-2744. https://doi.org/10.2174/15680266113136660196
Kundaković T, Kolundžić M. Therapeutic Properties of Mushrooms in Managing Adverse Effects in the Metabolic Syndrome. in Current topics in medicinal chemistry. 2013;13(21):2734-2744. doi:10.2174/15680266113136660196 .
Kundaković, Tatjana, Kolundžić, Marina, "Therapeutic Properties of Mushrooms in Managing Adverse Effects in the Metabolic Syndrome" in Current topics in medicinal chemistry, 13, no. 21 (2013):2734-2744, https://doi.org/10.2174/15680266113136660196 . .